TREAT-NMD will be attending the Parent Project aps 21st International Conference on Duchenne and Becker Muscular Dystrophy in Rome. CEO, David Allison, and Neil Bennett, Head of Real World Evidence will be discussing the PaLaDIn project, and ‘The Interactium’ an innovative platform for data collection.
TREAT-NMD news
TREAT-NMD goes to Florida!
TREAT-NMD are very excited to be attending the 2024 MDA Clinical & Scientific Conference in March in Orlando, Florida. Following our successful partnership at the 2023 event, we are delighted to announce that we will be partnering with MDA alongside the FSHD Society on the ‘Clinical Considerations’ track with a dedicated session focused on therapeutics for FSHD.
TREAT-NMD and collaborators launch a €21 million Patient Lifestyle and Disease Data Interactium (PaLaDIn) Project.
TREAT-NMD are proud to announce the launch of the PaLaDIn project, an incredibly exciting and ambitious new project that aims to accelerate research, understanding and treatment for neuromuscular and other rare diseases.
Happy 10th Anniversary to the Journal of Neuromuscular Diseases!
The Journal of Neuromuscular Diseases celebrates its 10 year anniversary!
TREAT-NMD Masterclass Event, Dubai 2024
We are planning to host an education event in a brand new region! Please register your interest for the TREAT-NMD Expert Masterclass Event 2024 (Dubai, UAE) or contact the Education Team for more details.
Becker Muscular Dystrophy Masterclass 2023: a visual summary!
A visual summary of the Expert Becker Muscular Dystrophy Masterclass – happy viewing!
